Top View
- Analysis of Fasl and TRAIL Induced Apoptosis Pathways in Glioma Cells
- Targeted Alpha Therapy Using a Novel CD70 Targeted Thorium-227 Conjugate in in Vitro and in Vivo Models of Renal Cell Carcinoma
- The TNF Superfamily
- Orange Blossom Trail & Zanja Trail
- Harbison State Forest Blaze Trail Name Distance Difficulty Level Forest Rules Firebreak 4.4 Miles Moderate Permits Required
- Digital Gene Expression Analysis of Epithelioid and Sarcomatoid Mesothelioma Reveals Differences in Immunogenicity
- CD154 Inhibits Death of T Cells Via a Cis Interaction with the Α5β1 Integrin
- Downloaded on June 15, 2021 From
- The Tumor Necrosis Factor Family: Family Conventions and Private Idiosyncrasies
- Middletown Trail Guide
- Mechanisms of Apoptosis Resistance to NK Cell-Mediated Cytotoxicity in Cancer
- Antibodies and Derivatives Targeting DR4 and DR5 for Cancer Therapy
- B-Cell Maturation Antigen Is Modified by a Single N-Glycan Chain That
- Osteoprotegerin Complexed with Its Decoy Receptor Crystal Structure Of
- BD Pharmingen™ Biotin Mouse Anti-Human CD154
- New Insights Into Apoptosis Signaling by Apo2l/TRAIL
- CD70-Restricted Specific Activation of TRAILR1 Or
- Apoptosis-Inducing Ligand (TRAIL), and This Information Is Current As TNF-Α During T Cell Activation of September 25, 2021
- Growth-Inhibitory Effects of CD40 Ligand (CD154) and Its Endogenous Expression in Human Breast Cancer1
- Bone Metabolism and RANKL/RANK/OPG Trail in Periodontal Disease Lukasz Czupkallo1*, Mansur Rahnama1, Dominik Kielbowicz1, Michal Lobacz1, Maryla Kozicka-Czupkallo2
- TRAIL-R1 and TRAIL-R2 Mediate TRAIL-Dependent Apoptosis in Activated Primary Human B Lymphocytes
- Death Receptor 5 (TNFRSF10B)
- N-Glycosylation of Mouse TRAIL-R and Human TRAIL-R1 Enhances TRAIL-Induced Death
- Anti-BAFF (B-Cell Activating Factor)
- ©Ferrata Storti Foundation
- The Role of Tumor Necrosis Factor Receptor Super-Family Member CD30 and Its Cognate Ligand CD30L for the Interplay of Immune Effector Cells
- Human OX40 Ligand/TNFSF4 Quantikine ELISA
- CD70-Restricted Specific Activation of TRAILR1 Or
- B Cell Maturation Protein Is a Receptor for the Tumor Necrosis Factor Family Member TALL-1
- The CD4+ T-Cell Help Signal Is Transmitted from APC to CD8+ T
- Determinants of Response and Mechanisms of Resistance of CAR T-Cell Therapy in Multiple Myeloma
- Golden Parks, Trails & Open Space
- Potent Immune Modulation by MEDI6383, an Engineered Human OX40 Ligand Igg4p Fc Fusion Protein Michael D
- Targeting Death-Inducing Receptors in Cancer Therapy
- Costimulatory Ligand CD70 Is Delivered to the Immunological Synapse by Shared Intracellular Trafficking with MHC Class II Molecules
- A Novel IL6R Antagonist, Inhibits IL6/STAT3 Signaling Pathway And
- Inhibition of P38 Mitogen-Activated Protein Kinase Unmasks a CD30-Triggered Apoptotic Pathway in Anaplastic Large Cell Lymphoma Cells
- Ligand Through TNF-Related Apoptosis-Inducing Production in T
- Oncolytic Vaccinia Virus Gene Modification and Cytokine Expression Effects on Tumor Infection, Immune Response, and Killing
- Sugarcreek Metropark • Trail
- Cells Abrogates Tolerance Induced by Apoptotic Activation-Induced
- TNF Receptor and Ligand Superfamilies
- Constitutive Gp130 Activation Rapidly Accelerates the Transformation of Human Hepatocytes Via an Impaired Oxidative Stress Response
- Osteoprotegerin and Receptor Activator of Nuclear Factor Kappab Ligand RANKL) Regulate Osteoclast Formation by Cells in the Human Rheumatoid Arthritic Joint
- SAHA/Vorinostat Induces the Expression of the CD137 Receptor
- Death Receptor 5 Displayed on Extracellular Vesicles Decreases
- The Crystal Structure of the Costimulatory OX40-OX40L Complex
- Chimeric Antigen Receptor Beyond CAR-T Cells
- Implication of NF-Κb and P53 in the Expression of TRAIL-Death
- Lethal T Cell Immunodeficiency Induced by Chronic Costimulation Via CD27-CD70 Interactions Kiki Tesselaar1,2,*, Ramon Arens1–3,*, Gijs M.W
- Activating the Interleukin-6-Gp130-STAT3
- Activation of OX40 and CD27 Costimulatory Signalling in Sheep Through Recombinant Ovine Ligands
- Regulation of Breast Cancer Cell Proliferation by APRIL